Cargando...
Use of immuno-oncology in melanoma
Treatment options for patients with metastatic melanoma have expanded rapidly since the approval of ipilimumab by the U.S. Food and Drug Administration in 2011. Cytokines such as interferon and interleukin-2 were approved in 1995 and 1998 respectively. However, the effect on survival was marginal, a...
Gardado en:
| Publicado en: | Curr Oncol |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Multimed Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194004/ https://ncbi.nlm.nih.gov/pubmed/32368174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5135 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|